Will Balaji Amines’ Share Price Keep Climbing in 2030? In this article, we’ll dive into the factors shaping Balaji Amines’ 2030 stock price outlook, offering insights for investors.
As of 13th November 2023, Balaji Animes is trading at Rs. 2,025 with a market cap of Rs. 6550 Crore.
About Balaji Amines
Balaji Amines Ltd, a prominent Indian chemical manufacturer, specializes in Ethylamines, Methylamines, specialty chemical derivatives, and Pharma Excipients. They offer a diverse portfolio of over 30 products, serving industries like Pharma, Agro, and chemicals.
With a global presence spanning 50+ countries, including the USA, UK, and Latin America, they generate 19% of their revenue from international markets. Their esteemed clientele includes Sun Pharmaceuticals, Dr. Reddy’s, Aurobindo Pharma, and Indian Oil, underscoring their commitment to excellence.
Operating five advanced facilities in Maharashtra and Telangana, they have a capacity of 2,31,000 MTPA for amines and derivatives, plus 45,000 MTPA for specialty chemicals. Recently completing Phase-1 of a Greenfield Project for Ethylamines, they’re poised for Phase-2 expansion with new products, subject to regulatory approvals, expected between mid-FY24 and FY25.
The market capitalization of the Balaji Amines is ₹7,222 crore, while the current stock price stands at ₹2,229. Balaji Amines Ltd faces competition from several key players in the chemical industry, including SRF, Gujarat Fluorochemicals, Tata Chemicals, and Linde India.
Q1 Fy2024 Key Points And Summary
- Revenue from Operations: In Q1FY24, the Balaji Amines’ revenue from operations was ₹469.32 crore, a decrease from ₹674.86 crore in Q1FY23. This represents a decline in revenue during the corresponding quarters.
- Total Volumes: The total volumes of products sold in Q1FY24 were 26,820 MT, down from 27,358 MT in Q1FY23. This indicates a decrease in the quantity of products sold.
- EBITDA: The EBITDA for Q1FY24 was ₹103.69 crore, significantly lower than ₹219.48 crore in Q1FY23. This substantial decline in EBITDA reflects a reduced operating profit. EBITDA Margin:
- The EBITDA margin for Q1FY24 was 22.09%, down from 32.52% in Q1FY23. The decrease in EBITDA margin indicates a lower percentage of operating profit compared to revenue.
- PAT (Profit After Tax): The PAT for Q1FY24 amounted to ₹67.68 crore, in contrast to ₹148.04 crore in Q1FY23. This demonstrates a decline in net profit after accounting for all expenses and taxes.
Overall, these financial figures indicate a challenging financial performance for the Balaji Amines in Q1FY24 compared to the same period in the previous fiscal year, with lower revenue, reduced profitability, and lower earnings per share.
Shareholding Pattern Analysis
The Balaji Amines’s shareholding pattern has been stable. As of June 2023, promoters hold the majority at 53.71%.
Foreign Institutional Investors (FIIs) increased their stake from 0.26% in March 2016 to 4.55% in June 2023, showing growing international interest.
Domestic Institutional Investors (DIIs) had varying ownership, peaking at 1.90% in March 2018 but declining to 0.18% in June 2023.
Public ownership fluctuated, reaching a low of 41.32% in March 2017 and a high of 44.33% in March 2020. As of June 2023, the public holds 41.57% of shares.
The number of shareholders surged from 6,665 in March 2016 to 1,40,957 in June 2023, indicating a growing investor base.
Balaji Amines Share Price Target 2023 To 2030
Balaji Amines Share Price Target 2023
When | Maximum Price | Minimum Price |
November 2023 | ₹2,292.42 | ₹2,084.01 |
December 2023 | ₹2,368.07 | ₹2,152.79 |
- Balaji Amines’s maximum share price for 2023 is expected to reach ₹2,385.03, reflecting the highest valuation of the stock expected during the entire year.
- Conversely, the minimum share price for the year is expected to be ₹2,084.01.
Balaji Amines’ share price is expected to fluctuate in 2023, hitting its highest point at ₹2,646.03 in January 2023 and its lowest at ₹1,880.00 in March.
Balaji Amines Share Price Target 2024
When | Maximum Price | Minimum Price |
January 2024 | ₹2,416.39 | ₹2,101.21 |
February 2024 | ₹2,465.71 | ₹2,144.09 |
March 2024 | ₹2,516.03 | ₹2,187.85 |
April 2024 | ₹2,442.75 | ₹2,124.13 |
May 2024 | ₹2,406.65 | ₹2,092.74 |
June 2024 | ₹2,493.29 | ₹2,168.07 |
July 2024 | ₹2,468.35 | ₹2,146.39 |
August 2024 | ₹2,567.09 | ₹2,232.25 |
September 2024 | ₹2,669.77 | ₹2,321.54 |
October 2024 | ₹2,617.42 | ₹2,276.02 |
November 2024 | ₹2,695.94 | ₹2,344.30 |
December 2024 | ₹2,763.34 | ₹2,402.91 |
Looking ahead to year 2024, we can anticipate the following trends for the entire year:
- Balaji Amines’ highest share price for the year to occur in December 2024, reaching ₹2,763.34.
- Conversely, we anticipate the lowest share price for the year to be recorded in January 2024, at ₹2,101.21.
Balaji Amines Share Price Target 2025
when | Maximum Price | Minimum Price |
January 2025 | ₹2,818.61 | ₹2,168.16 |
February 2025 | ₹2,890.88 | ₹2,223.76 |
March 2025 | ₹3,003.63 | ₹2,310.48 |
April 2025 | ₹2,944.73 | ₹2,265.18 |
May 2025 | ₹2,858.96 | ₹2,199.20 |
June 2025 | ₹2,987.62 | ₹2,298.17 |
July 2025 | ₹2,929.04 | ₹2,253.10 |
August 2025 | ₹3,019.62 | ₹2,322.79 |
September 2025 | ₹3,125.31 | ₹2,404.09 |
October 2025 | ₹3,206.57 | ₹2,466.59 |
November 2025 | ₹3,286.73 | ₹2,528.26 |
December 2025 | ₹3,368.90 | ₹2,591.46 |
- Balaji Amines’ highest share price for the year is expected to be recorded in December 2025, reaching ₹3,368.90.
- In contrast, the lowest share price for the year is expected to be observed in January 2025, at ₹2,168.16.
It’s clear from our analysis that fluctuations are expected to occur in the year 2025. The highest point of the year is expected to be in December at ₹3,368.90, suggesting investor confidence or positive company news.
Conversely, the lowest point is expected to occur in January at ₹2,168.16, indicating a performance dip, possibly due to market conditions or company-specific factors.
These price swings are expected to showcase stock market dynamics, influenced by various factors. Investors and analysts are expected to closely watch such shifts to guide their investment choices. The price range is expected to offer insights into the stock’s volatility and potential opportunities or risks in the year.
Balaji Amines Share Price Target 2026 To 2030
Year | Maximum Price (₹) | Minimum Price (₹) |
---|---|---|
2026 | ₹3,537.35 | ₹2,476.14 |
2027 | ₹3,891.08 | ₹2,723.76 |
2028 | ₹5,447.51 | ₹2,723.76 |
2029 | ₹4,716.46 | ₹2,358.23 |
2030 | ₹6,131.40 | ₹4,291.98 |
In 2026, it is anticipated that the share price will range from a stable ₹3,537.35 (maximum) to ₹2,476.14 (minimum). Transitioning to 2027, it is expected that the maximum share price will rise to ₹3,891.08, possibly indicating investor confidence, while the minimum is expected to remain steady at ₹2,723.76.
The year 2028 is expected to witness a significant surge. The maximum share price is expected to reach ₹5,447.51, possibly due to market optimism or company achievements. Remarkably, the minimum price is expected to hold at ₹2,723.76, underscoring price stability in the lower range.
In 2030, both the maximum and minimum share prices are expected to see significant increases. The maximum is expected to soar to ₹6,131.40, suggesting substantial growth and heightened investor enthusiasm, while the minimum is also expected to rise to ₹4,291.98, indicating a higher baseline value.
Balaji Amines Financial Condition (Last 5 Years)
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
Sales + (Crores Rs) |
940 | 935 | 1,308 | 2,314 | 2,346 |
Expenses + (Crores Rs) |
747 | 754 | 935 | 1,691 | 1,736 |
Operating Profit (Crores Rs) |
193 | 181 | 373 | 623 | 609 |
OPM % | 21% | 19% | 29% | 27% | 26% |
Other Income + (Crores Rs) |
4 | 5 | 6 | 15 | 15 |
Interest (Crores Rs) |
13 | 23 | 18 | 17 | 12 |
Depreciation (Crores Rs) |
20 | 32 | 34 | 42 | 46 |
Profit before tax (Crores Rs) |
165 | 131 | 327 | 578 | 567 |
Tax % | 29% | 26% | 25% | 28% | 28% |
Net Profit + (Crores Rs) |
117 | 97 | 243 | 418 | 406 |
EPS in Rs | 36.27 | 32.34 | 73.51 | 113.71 | 100.47 |
Dividend Payout % | 8% | 10% | 5% | 5% | 10% |
- Balaji Amines Sales Growth: Over the five-year period from March 2019 to March 2023, the company’s sales steadily increased, rising from 940 units to 2,346 units.
- Operating Profit: Balaji Amines’ operating profit showed positive growth, with a notable increase from 193 units in March 2019 to 609 units in March 2023.
- Other Income: Other income, which includes non-operational sources of revenue, remained steady at 15 units from March 2021 to March 2023.
- Tax Percentage: The tax percentage ranged from 25% to 29%, showing the company’s tax efficiency over the years.
- Net Profit: The net profit increased from 117 units in March 2019 to 406 units in March 2023.
- Earnings Per Share (EPS): The EPS grew consistently from ₹36.27 in March 2019 to ₹100.47 in March 2023, demonstrating an increase in earnings attributable to each share.
- Dividend Payout: The dividend payout percentage ranged from 5% to 10%, indicating the company’s distribution of profits to shareholders while retaining a portion for reinvestment.
Balaji Amines‘s financial performance indicates a strong and sustainable growth trajectory, efficient operations, and prudent financial management. These factors collectively contribute to its ability to generate increasing profits and shareholder value over the analyzed period.
FAQs
What Is the Current Share Price?
The current share price is ₹2,229.
What Is the Current Valuation of Balaji Amines – Market Cap?
The current valuation of Balaji Amines is ₹7,222 Crores (₹7,222 Cr.) based on its market capitalization.
What Is The Target Share Price For Balaji Amines By 2024?
What Is The Target Share Price For Balaji Amines By 2025?
What Is The Target Share Price For Balaji Amines By 2030?
What Is Balaji Amines‘s Return on Equity (ROE) Trend Over the Years?
Balaji Amines has demonstrated a consistent trend in its Return on Equity (ROE) over various time periods:
- Over the last 10 years, the ROE averaged 25%.
- In the past 5 years, it increased slightly to 26%.
- Over the most recent 3 years, the ROE showed further improvement, reaching 29%.
- In the last fiscal year, the ROE was at 23%.
- Currently, the company’s ROE stands at 23.2%.
Should One Invest in Balaji Amines?
Considering the provided information, Balaji Amines presents positive investment indicators. It showcases financial strength and growth, notably reducing its debt, nearly achieving a debt-free status, and maintaining a strong profit growth at a 23.6% CAGR over five years.
Furthermore, Balaji Amines exhibits a solid Return on Equity (ROE) track record, boasting a three-year ROE of 28.6%. The improved debtor days from 79.0 to 58.8 days signify efficient accounts receivable management.
Yet, it’s crucial to address the recent weak quarterly performance with a significant profit decline (-57.12%) and a sales decrease (-30.81%). Investigating the causes behind this dip is essential.
Despite Q1FY24’s financial challenges, Balaji Amines is advancing positively:
- New Projects: The N-butylamine and Methyl amine plants are progressing well, showing the company’s commitment to expanding production.
- Future Expansion: Plans for a dimethyl ether plant and DMAHCL plant signal a focus on diversifying and strengthening the product portfolio.
- Export and Revenue Targets: Ambitious goals include 20-22% exports and INR 4,000 crores in revenue in the near future, reflecting confidence in growth.
- Sectoral Improvements: Anticipated positive developments in pharmaceutical and agrochemical markets may benefit the company.
In conclusion, despite Q1FY24 challenges, Balaji Amines is actively pursuing growth through strategic initiatives. Investors should consider these alongside recent performance when evaluating investment potential.
Prospective investors should scrutinize the reasons for the recent underperformance, determining if it’s a short-term setback or a more concerning issue. Additionally, considering the company’s overall financial health and historical performance is vital.
In summary, while Balaji Amines has a strong foundation and growth history, recent weak quarterly results necessitate a thorough assessment of the company’s current situation and recovery prospects. Investing decisions should be well-informed and may benefit from expert financial advice.